SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Smulders Y. M.)
 

Sökning: WFRF:(Smulders Y. M.) > EULAR recommendatio...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007196naa a2200985 4500
001oai:gup.ub.gu.se/260468
003SwePub
008240528s2017 | |||||||||||000 ||eng|
009oai:DiVA.org:umu-131644
009oai:lup.lub.lu.se:58c284e2-143e-4ee8-87fe-3484a06f96ac
024a https://gup.ub.gu.se/publication/2604682 URI
024a https://doi.org/10.1136/annrheumdis-2016-2097752 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1316442 URI
024a https://lup.lub.lu.se/record/58c284e2-143e-4ee8-87fe-3484a06f96ac2 URI
040 a (SwePub)gud (SwePub)umud (SwePub)lu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Agca, R.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
2451 0a EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
264 c 2016-10-03
264 1b BMJ,c 2017
520 a Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European League Against Rheumatism (EULAR) taskforce recommended screening, identification of CVD risk factors and CVD risk management largely based on expert opinion. In view of substantial new evidence, an update was conducted with the aim of producing CVD risk management recommendations for patients with IJD that now incorporates an increasing evidence base. A multidisciplinary steering committee (representing 13 European countries) comprised 26 members including patient representatives, rheumatologists, cardiologists, internists, epidemiologists, a health professional and fellows. Systematic literature searches were performed and evidence was categorised according to standard guidelines. The evidence was discussed and summarised by the experts in the course of a consensus finding and voting process. Three overarching principles were defined. First, there is a higher risk for CVD in patients with RA, and this may also apply to ankylosing spondylitis and psoriatic arthritis. Second, the rheumatologist is responsible for CVD risk management in patients with IJD. Third, the use of non-steroidal anti-inflammatory drugs and corticosteroids should be in accordance with treatment-specific recommendations from EULAR and Assessment of Spondyloarthritis International Society. Ten recommendations were defined, of which one is new and six were changed compared with the 2009 recommendations. Each designated an appropriate evidence support level. The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased. This underscores the need for CVD risk management in these patients. These recommendations are defined to provide assistance in CVD risk management in IJD, based on expert opinion and scientific evidence.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Allmänmedicin0 (SwePub)302242 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex General Practice0 (SwePub)302242 hsv//eng
653 a Adrenal Cortex Hormones/therapeutic use
653 a Anti-Inflammatory Agents
653 a Non-Steroidal/therapeutic use
653 a Antirheumatic Agents/therapeutic use
653 a Arthritis
653 a Psoriatic/complications/drug therapy
653 a Arthritis
653 a Rheumatoid/complications/drug therapy
653 a Cardiovascular Diseases/etiology/*prevention & control
653 a Directive Counseling
653 a Humans
653 a Life Style
653 a *Physician's Role
653 a *Rheumatology
653 a Risk Assessment
653 a Risk Factors
653 a *Risk Management/methods
653 a Spondylitis
653 a Ankylosing/complications/drug therapy
653 a *Ankylosing Spondylitis
653 a *Cardiovascular Disease
653 a *Psoriatic Arthritis
653 a *Rheumatoid Arthritis
700a Heslinga, S. C.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a Rollefstad, S.u Diakonhjemmet Hospital4 aut
700a Heslinga, M.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a McInnes, I. B.u University of Glasgow4 aut
700a Peters, M. J.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a Kvien, T. K.u Diakonhjemmet Hospital4 aut
700a Dougados, M.u Paris Descartes University,University of Manchester4 aut
700a Radner, H.u Medical University of Vienna4 aut
700a Atzeni, F.u Istituto Ortopedico Galeazzi4 aut
700a Primdahl, J.u University of Southern Denmark,Hospital of Southern Jutland4 aut
700a Södergren, Annau Umeå University,Umeå universitet,Reumatologi4 aut0 (Swepub:umu)anayxt97
700a Wållberg Jonsson, Solveigu Umeå University,Umeå universitet,Reumatologi4 aut0 (Swepub:umu)sowa0001
700a van Rompay, J.u PARE (patient research partners)4 aut
700a Zabalan, C.4 aut
700a Pedersen, T. R.u University of Oslo4 aut
700a Jacobsson, Lennart T. H.,d 1954u University of Gothenburg,Lund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)orto-lja
700a de Vlam, K.u University Hospitals Leuven4 aut
700a Gonzalez-Gay, M. A.u University of Cantabria4 aut
700a Semb, A. G.u Diakonhjemmet Hospital4 aut
700a Kitas, G. D.u University of Manchester4 aut
700a Smulders, Y. M.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
700a Szekanecz, Z.u University of Debrecen4 aut
700a Sattar, N.u University of Glasgow4 aut
700a Symmons, D. P.4 aut
700a Nurmohamed, M. T.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
710a Amsterdam UMC - Vrije Universiteit Amsterdamb Diakonhjemmet Hospital4 org
773t Ann Rheum Disd : BMJg 76:1, s. 17-28q 76:1<17-28x 0003-4967x 1468-2060
773t Annals of the Rheumatic Diseasesd : BMJg 76:1, s. 17-28q 76:1<17-28x 1468-2060
856u https://ard.bmj.com/content/annrheumdis/76/1/17.full.pdf
856u http://dx.doi.org/10.1136/annrheumdis-2016-209775y FULLTEXT
8564 8u https://gup.ub.gu.se/publication/260468
8564 8u https://doi.org/10.1136/annrheumdis-2016-209775
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-131644
8564 8u https://lup.lub.lu.se/record/58c284e2-143e-4ee8-87fe-3484a06f96ac

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy